Cover of: Heart and heart-lung transplantation | Read Online

Heart and heart-lung transplantation

  • 311 Want to read
  • ·
  • 24 Currently reading

Published by Saunders in Philadelphia .
Written in English


  • Heart -- Transplantation.,
  • Lungs -- Transplantation.,
  • Heart -- transplantation.,
  • Lung -- transplantation.

Book details:

Edition Notes

Includes bibliographies and index.

Statementedited by John Wallwork.
ContributionsWallwork, John, 1946-
LC ClassificationsRD598 .H4235 1989
The Physical Object
Paginationxx, 566 p. :
Number of Pages566
ID Numbers
Open LibraryOL2030515M
ISBN 100721627870
LC Control Number88006019

Download Heart and heart-lung transplantation


From Lung Transplantation to Heart-Lung Transplantation [Jianxing He, Xin Xu, Selim M. Arcasoy. Anne Olland] on *FREE* shipping on qualifying offers. The past decades have witnessed a dramatic increase in the research on lung and heart-lung transplantation. With the aim to provide a comprehensive review on lung and heart-lung transplantation. An excellent resource for practitioners who participate in the care of transplant patients, this comprehensive new second edition covers all aspects of heart and lung transplantation. Each area of the field is fully addressed, with documentation and practical points for patient management provided throughout. An especially notable feature of this new edition is the . ISBN: OCLC Number: Notes: Revised edition of: Heart and heart-lung transplantation. Description: xvii, pages. This is the first book to focus purely on interpreting biopsy pathology specimens from heart and heart/lung transplant patients. Each chapter contains a brief introduction covering the clinical conditions seen in these patients, followed by a large body of colour photographs explained by detailed captions to give a comprehensive overview of the subject.

Dr. Grady’s research on health-related quality of life outcomes after heart transplantation and mechanical circulatory support has been funded by the American Heart Association and National Institutes of Health. She has published articles and 10 book chapters. Dr.   Combined heart-lung transplantation remains the only definitive therapy for patients who have both end-stage heart failure and end-stage lung failure. The most common indication is congenital heart disease (CHD) and the proportion is increasing for acquired heart disease concomitant with pulmonary hypertension and/or intrinsic lung by: The International Society for Heart and Lung Transplantation. A Society that Includes Basic Science, the Failing Heart and Advanced Lung Disease. This volume provides a definitive look at heart, lung, and heart-lung transplantation. Including historical background on these procedures, the volume discusses the immunological basis of transplantation, organ preservation, donor procurement, pre-transplant recipient management, operative techniques, post-operative care, pathology, special considerations (cystic fibrosis, Format: Hardcover.

The International Heart and Lung Transplantation (ISHLT) Registry summarized the distribution of diagnoses leading to adult heart-lung transplantation from January to June (see the slides Adult Heart/Lung Transplantation Statistics). The three leading indications were congenital heart disease ( percent), IPAH ( percent. The International Society for Heart and Lung Transplantation (ISHLT), established in , is a professional organization committed to research and education in heart and lung disease and transplantation. It holds annual scientific meetings and publishes The Journal of Heart and Lung Transplantation. It also holds the largest registry of heart and lung transplant data in the world, Headquarters: Texas. Heart and Lung Transplant Treatment Generally, you are eligible for transplantation only if your daily functioning is severely impaired by your heart or lung condition, and medical treatment and lifestyle changes have not helped in improving your condition. from the International Society of Heart and Lung Transplantation (ISHLT), in only heart, lung, and 39 heart-lung patients underwent trans-plantation in all of North America [5,6]. The most important factor that limits use of thoracic organ transplantation for these near-death patients is the lack of availability of donor organs.